We are live on ! Find out more
FRM

Fox Run Management Portfolio holdings

AUM $572M
1-Year Est. Return 24.16%
This Fund
S&P 500
This Quarter Est. Return
+5.86%
1 Year Est. Return
+24.16%
3 Year Est. Return
+44.85%
5 Year Est. Return
+32.84%
10 Year Est. Return
+244.98%
AUM
$245M
AUM Growth
+$54.9M
Cap. Flow
+$50.7M
Cap. Flow %
20.67%
Top 10 Hldgs %
5.1%
Holding
864
New
386
Increased
90
Reduced
68
Closed
320

Top Buys

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$1.38M
2
DVN icon
Devon Energy
DVN
+$1.34M
3
DIS icon
Walt Disney
DIS
+$1.23M
4
IART icon
Integra LifeSciences
IART
+$1.2M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.15M

Top Sells

Rank Stock Value
1
AMT icon
American Tower
AMT
+$1.02M
2
GILD icon
Gilead Sciences
GILD
+$1.02M
3
UGI icon
UGI
UGI
+$884K
4
AVNS icon
Avanos Medical
AVNS
+$880K
5
GIL icon
Gildan
GIL
+$870K

Sector Composition

Rank Sector Weight
1 Healthcare 13.53%
2 Technology 12.85%
3 Industrials 12.5%
4 Consumer Discretionary 12.47%
5 Financials 10.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WP
826
DELISTED
Worldpay, Inc.
WP
– –
-4,100
Closed -$244K
HZNP
827
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-12,000
Closed -$194K
TFCF
828
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
– –
-20,500
Closed -$559K
NTRI
829
DELISTED
NutriSystem, Inc.
NTRI
– –
-12,900
Closed -$447K
NXTM
830
DELISTED
NxStage Medical Inc.
NXTM
– –
-22,900
Closed -$600K
FBR
831
DELISTED
Fibria Celulose Sa
FBR
– –
-40,300
Closed -$387K
KERX
832
DELISTED
Keryx Biopharmaceuticals Inc
KERX
– –
-10,600
Closed -$62K
OCLR
833
DELISTED
Oclaro Inc.
OCLR
– –
-14,600
Closed -$131K
COL
834
DELISTED
Rockwell Collins
COL
– –
-7,400
Closed -$686K
KLXI
835
DELISTED
KLX Inc.
KLXI
– –
-7,946
Closed -$302K
LQ
836
DELISTED
La Quinta Holdings Inc.
LQ
– –
-25,000
Closed -$355K
CBI
837
DELISTED
Chicago Bridge & Iron Nv
CBI
– –
-6,800
Closed -$216K
IPXL
838
DELISTED
Impax Laboratories, Inc.
IPXL
– –
-23,500
Closed -$311K
CSRA
839
DELISTED
CSRA Inc.
CSRA
– –
-16,600
Closed -$529K
CAA
840
DELISTED
CalAtlantic Group, Inc.
CAA
– –
-8,500
Closed -$289K
BV
841
DELISTED
Bazaarvoice, Inc.
BV
– –
-16,300
Closed -$79K
HSNI
842
DELISTED
HSN, Inc.
HSNI
– –
-12,000
Closed -$412K
CEMP
843
DELISTED
Cempra, Inc.
CEMP
– –
-30,400
Closed -$85K
SHOR
844
DELISTED
ShoreTel, Inc.
SHOR
– –
-11,200
Closed -$80K
WBMD
845
DELISTED
WebMD Health Corp.
WBMD
– –
-5,000
Closed -$248K
MACK
846
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
– –
-2,707
Closed -$87K
MBLY
847
DELISTED
Mobileye N.V.
MBLY
– –
-12,800
Closed -$488K
KCG
848
DELISTED
KCG Holdings, Inc.
KCG
– –
-20,400
Closed -$270K
ARIA
849
DELISTED
Ariad Pharmaceuticals Inc
ARIA
– –
-13,300
Closed -$165K
NLSN
850
DELISTED
Nielsen Holdings plc
NLSN
– –
-7,000
Closed -$294K
31 32 33
34
35

Similar funds

MAM
McLean Asset Management Tysons, Virginia $572M AUM 22% 1-Year Est. Return
NA
Nordwand Advisors Radnor, Pennsylvania $572M AUM 23.09% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $572M AUM 67.49% 1-Year Est. Return
MW
Marble Wealth Montgomery, Alabama $571M AUM
BSG
Black Swift Group Boulder, Colorado $571M AUM 36.77% 1-Year Est. Return
RI
RPTC Inc Jackson, Wyoming $571M AUM 19.82% 1-Year Est. Return
XI
XXEC Inc Tulsa, Oklahoma $571M AUM 1.42% 1-Year Est. Return
TWA
Tulsa Wealth Advisors Tulsa, Oklahoma $570M AUM

Fox Run Management's Q1 2017 Portfolio in Review

As of Q1 2017, Fox Run Management held 864 positions worth $245M, up 29% from $190M the previous quarter. Its ten largest holdings account for 5.1% of the portfolio.

Fox Run Management deployed $50.7M of net new capital in Q1 2017, opening 386 new positions and adding to 90 existing holdings. Its largest new stake was Edwards Lifesciences: 44,100 shares worth $1.38M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was UGI, an estimated $884K trimmed.

  • Fox Run Management's largest Q1 2017 buy was Edwards Lifesciences: 44,100 shares worth $1.38M.
  • Fox Run Management added most to Capri Holdings in Q1 2017, an estimated $746K increase.
  • Fox Run Management's biggest Q1 2017 reduction was UGI, cutting an estimated $884K.
  • Fox Run Management fully exited American Tower in Q1 2017, selling an estimated $1.02M.
  • Fox Run Management's ten largest holdings make up 5.1% of its $245M portfolio in Q1 2017.
  • Fox Run Management opened 386 new positions and closed 320 in Q1 2017.
  • Fox Run Management's portfolio value rose 29% quarter-over-quarter to $245M.

Based on Fox Run Management's 13F filing for Q1 2017, filed 17 Apr 2017.